Biopolym. Cell. 1993; 9(5):44-51.
http://dx.doi.org/10.7124/bc.000370
Structure and Function of Biopolymers
The fractionation of eukaryotic dna by pulsed field gel electrophoresis. Evidence for nuclear DNA organization as constituent component of topoisomerase II/DNA complex
1Solovyan V. T., 1Andreyev I. O., 1Kunakh V. A.
  1. Institute of Molecular Biology and Genetics, NAS of Ukraine
    150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680

Abstract

We investigated the pattern variation of discrete DNA fragments resulted from fractionation of nuclear DNA preparations by field inversion gel electrophoresis in response to different influences. The discrete cleavage of nuclear DNA has been shown to be SDS-dependent in Mg2+-containing medium and SDS-independent in Ca2+-containing one. Topoisomerase II specific poisons teniposide (VM-26) and amsacrine (m-AMSA) have been shown to increase the SDS-dependent nuclear DNA cleavage while NaCl promotes to rejoining of cleaved DNA. The data presented allow to considere the nuclear DNA organization as constituent component of topoisomerase II/DNA complex the main property of which is its ability to mediate the cleavage/rejoining equilibrium-reactions. The involvement of nuclear DNA in functioning topoII/DNA complex offers the possibility to investigate the role of topoll enzyme in structural organization and functioning of eukaryotic genome.
Full text: (PDF, in Russian)

References

[1] SolovÄ­an VT, Kunakh VA. Fractionation of eukaryotic DNA in a pulsating electrical field. I. Detection and properties of discrete DNA fragments. Mol Biol (Mosk). 1991;25(4):1071-9.
[2] Solov'ian VT, Andreev IO, Kunakh VA. Fractionation of eukaryotic DNA in a pulsed electrical field. II. Discrete DNA fragments and level of structural organization of chromatin. Mol Biol (Mosk). 1991;25(6):1483-91.
[3] Nelson EM, Tewey KM, Liu LF. Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide. Proc Natl Acad Sci U S A. 1984;81(5):1361-5.
[4] Liu LF. DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem. 1989;58:351-75.
[5] Halligan BD, Edwards KA, Liu LF. Purification and characterization of a type II DNA topoisomerase from bovine calf thymus. J Biol Chem. 1985;260(4):2475-82.
[6] Zwelling LA. DNA topoisomerase II as a target of antineoplastic drug therapy. Cancer Metastasis Rev. 1985;4(4):263-76.
[7] Glisson BS, Ross WE. DNA topoisomerase II: a primer on the enzyme and its unique role as a multidrug target in cancer chemotherapy. Pharmacol Ther. 1987;32(2):89-106.
[8] Ross WE. DNA topoisomerases as targets for cancer therapy. Biochem Pharmacol. 1985;34(24):4191–5.
[9] Osheroff N. Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide. Biochemistry. 1989;28(15):6157-60.
[10] Sander M, Hsieh T. Double strand DNA cleavage by type II DNA topoisomerase from Drosophila melanogaster. J Biol Chem. 1983;258(13):8421-8.
[11] Liu LF, Rowe TC, Yang L, Tewey KM, Chen GL. Cleavage of DNA by mammalian DNA topoisomerase II. J Biol Chem. 1983;258(24):15365-70.
[12] Osheroff N, Zechiedrich EL. Calcium-promoted DNA cleavage by eukaryotic topoisomerase II: trapping the covalent enzyme-DNA complex in an active form. Biochemistry. 1987;26(14):4303-9.
[13] Earnshaw WC, Heck MM. Localization of topoisomerase II in mitotic chromosomes. J Cell Biol. 1985;100(5):1716-25.
[14] Gasser SM, Laemmli UK. The organisation of chromatin loops: characterization of a scaffold attachment site. EMBO J. 1986;5(3):511-8.
[15] Berrios M, Osheroff N, Fisher PA. In situ localization of DNA topoisomerase II, a major polypeptide component of the Drosophila nuclear matrix fraction. Proc Natl Acad Sci U S A. 1985;82(12):4142-6.
[16] Filipski J, Leblanc J, Youdale T, Sikorska M, Walker PR. Periodicity of DNA folding in higher order chromatin structures. EMBO J. 1990;9(4):1319-27.